LANZAFAME, Massimiliano
 Distribuzione geografica
Continente #
NA - Nord America 2.184
EU - Europa 1.701
AS - Asia 1.312
SA - Sud America 208
AF - Africa 27
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 5.440
Nazione #
US - Stati Uniti d'America 2.146
SG - Singapore 544
CN - Cina 490
GB - Regno Unito 489
BR - Brasile 191
SE - Svezia 189
IT - Italia 169
DE - Germania 162
IE - Irlanda 156
FR - Francia 144
HK - Hong Kong 140
RU - Federazione Russa 137
FI - Finlandia 131
UA - Ucraina 36
KR - Corea 30
VN - Vietnam 28
CA - Canada 20
CZ - Repubblica Ceca 20
JP - Giappone 18
TR - Turchia 14
BE - Belgio 13
ZA - Sudafrica 13
NL - Olanda 11
ID - Indonesia 9
IN - India 9
MX - Messico 9
AR - Argentina 8
BF - Burkina Faso 8
AT - Austria 7
BD - Bangladesh 5
CO - Colombia 5
IQ - Iraq 5
PL - Polonia 5
ES - Italia 4
AU - Australia 3
CH - Svizzera 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
GT - Guatemala 3
HU - Ungheria 3
IL - Israele 3
LT - Lituania 3
PK - Pakistan 3
RO - Romania 3
SA - Arabia Saudita 3
EC - Ecuador 2
EE - Estonia 2
EU - Europa 2
HR - Croazia 2
MY - Malesia 2
NZ - Nuova Zelanda 2
SK - Slovacchia (Repubblica Slovacca) 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
CD - Congo 1
CL - Cile 1
CR - Costa Rica 1
DZ - Algeria 1
EG - Egitto 1
GE - Georgia 1
GR - Grecia 1
JM - Giamaica 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MA - Marocco 1
MN - Mongolia 1
NO - Norvegia 1
RS - Serbia 1
TG - Togo 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UG - Uganda 1
VE - Venezuela 1
Totale 5.440
Città #
Southend 416
Chandler 389
Singapore 278
Jacksonville 244
Woodbridge 234
Dallas 176
Dublin 155
Ann Arbor 140
Hong Kong 140
Ashburn 123
Beijing 97
Lawrence 53
Princeton 53
Helsinki 48
Jinan 45
Munich 44
Nanjing 44
Shenyang 43
Wilmington 43
Houston 40
New York 39
Verona 36
Hebei 21
Turku 20
Los Angeles 19
The Dalles 19
Brno 18
Boardman 16
Bologna 16
Santa Clara 16
Seoul 16
Tianjin 16
Tokyo 16
Ningbo 15
Council Bluffs 14
Haikou 14
Zhengzhou 14
Bloomsbury 13
Brussels 13
Sindelfingen 13
Changsha 12
Hangzhou 11
Nanchang 11
San Francisco 11
Taizhou 11
Columbus 10
Frankfurt am Main 10
Jiaxing 10
Milan 10
Redmond 10
Toronto 10
Guangzhou 9
Norwalk 9
Redwood City 9
São Paulo 9
Dong Ket 8
Fuzhou 8
Ouagadougou 8
Rio de Janeiro 8
Boston 7
Brooklyn 7
Buffalo 7
Clearwater 7
Jakarta 7
Lanzhou 7
London 7
Nuremberg 7
Seattle 7
Atlanta 6
Belo Horizonte 6
Falls Church 6
Ho Chi Minh City 6
Johannesburg 6
Taiyuan 6
Washington 6
Pignone 5
Warsaw 5
Bursa 4
Chennai 4
Fairfield 4
Guarulhos 4
Riva 4
Scandiano 4
Stockholm 4
Vicenza 4
Brugherio 3
Budapest 3
Caxias do Sul 3
Chicago 3
Curitiba 3
Düsseldorf 3
Giussano 3
Guatemala City 3
Monterrey 3
Montreal 3
Moscow 3
Redondo Beach 3
Santa Cruz do Sul 3
Allerød Municipality 2
Amsterdam 2
Totale 3.543
Nome #
Performance of alere determine HIV-1/2 Ag/Ab combo rapid test for acute HIV infection: A case report | Performance del test rapido Alere Determine HIV-1/2 Ag/Ab Combo nell?infezione acuta da HIV: Un caso clinic 179
Benign acute viral myositis in African migrants: a clinical, serological and pathological study. 144
Disseminated Mycobacterium chimaera infection after open heart surgery in an Italian woman: a case report and a review of the literature 141
Cryptococcal dermatitis with negative antigenaemia heralding disseminated disease in HIV infection. 140
Dolutegravir Monotherapy in HIV-Infected Naive Patients With <100,000 Copies/mL HIV RNA Load 135
HIV-1-associated neurocognitive disorders: is HLA-C binding stability to β2-microglobulin a missing piece of the pathogenetic puzzle? 132
Acute mediastinitis: a severe complication of transdermal therapy in a patient with ischaemic heart disease. A case report. 130
Successful Antifungal Combination Therapy and Surgical Approach for Aspergillus fumigatus Suppurative Thyroiditis Associated with Thyrotoxicosis and Review of Published Reports 128
Primary cutaneous cryptococcosis in a HIV infested patient: case report. 126
A 58-year-old man with B-cell chronic lymphocytic leukemia and multiple strokes 126
Dolutegravir monotherapy in HIV-1-suppressed patients: A feasible regimen in real life 121
Dolutegravir 50 mg thrice weekly plus atazanavir 400 mg daily in a long-term virologically suppressed HIV-infected patient 120
Pneumatocoele formation during Pneumocystis carinii pneumonia in a man with HIV-1 infection. 114
Histoplasmosis in two human immunodeficiency virus-positive immigrants to Italy: clinical features and management in the highly active antiretroviral therapy era. 113
Raltegravir/nevirapine dual therapy at reduced doses as 'maintenance' treatment in virally suppressed HIV-infected patients 113
No improvement of lipodystrophy syndrome in an HIV-infected patient. 111
'High' antiretroviral deintensification strategy and cellular HIV DNA levels 111
Unusual rapidly growing ulcerative genital mass due to herpes simplex virus in uman immunodeficiency virus-infected woman 110
Prevalence of Strongyloides stercoralis infection among HIV-positive immigrants attending two Italian hospitals, from 2000 to 2009. 110
Discontinuation of non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy: clinical implications in patients on CD4 T-cell-guided treatment interruption. 107
Recreational substance use and tolerance of efavirenz in HIV-1 infected patients 105
Dual therapy with a combination of unboosted atazanavir and lamivudine as maintenance treatment in virologically suppressed HIV-1-infected patients 105
Dolutegravir monotherapy in HIV-infected naive patients with an HIV-RNA load <100 000 copies/mL: a medium-term follow-up 104
Can we really identify HIV-1 long-term nonprogressors? 103
Antiretroviral therapy in low-resource settings 103
Monoclonal gammopathy in HIV-Infected patients on stable antiretroviral therapy: disappearance or deep reduction? 101
Oxaliplatin Based Chemotherapy and Concomitant Highly Active Antiretroviral Therapy in the Treatment of 24 Patients with Colorectal Cancer and HIV Infection 98
Efavirenz dose reduction is associated with improved lipid profile in HIV-1 infected patients 98
Is there a role for TNF-alpha in HIV1-associated lipodystrophy? 97
Enanthema as the first clinical manifestation of abacavir hypersensitivity reaction: a case report. 97
Raltegravir: is a 400 mg once-daily dose enough? 97
Efficacy and safety of abacavir/lamivudine with raltegravir in treatment-experienced and treatment-naïve patients with HIV-1 infection: an observational, retrospective, multi-centre study 96
Low plasmatic concentration of intensified antiretroviral therapy in a pregnant woman: a case report 95
Relationship between vertebral fractures, bone mineral density, and osteometabolic profile in HIV and Hepatitis B and C-infected patients treated with ART 94
Immunovirological outcome and HIV-1 DNA decay in a small cohort of HIV-1-infected patients deintensificated from Abacavir/Lamivudine/Dolutegravir to Lamivudine plus Dolutegravir 93
Short-Cycle Therapy (5 days on/2 days off) with a lamivudine-dolutegravir two-drug regimen in a cohort of virologically suppressed HIV-infected patients 92
Inflammatory pseudotumor of lymph nodes. 91
Quantitative Trait Loci for CD4:CD8 Lymphocyte Ratio Are Associated with Risk of Type 1 Diabetes and HIV-1 Immune Control 90
The major genetic determinants of HIV-1 control affect HLA Class I Peptide presentation 90
Darunavir/ritonavir 600/100 mg once daily: it's time for larger non-inferiority randomized trials 87
Disappearance of Renal Stones in an HIV-1-Infected Patient After Reduction of Atazanavir Dose 85
No influence of nevirapine on vitamin D deficiency in HIV-infected patients 84
Efficacy and safety of TAM-sparing antiretroviral regimens in naive HIV-positive patients 84
Prevalence and clinical significance of Ureaplasma urealyticum and Mycoplasma hominis in the lower genital tract of HIV-1-infected women. 83
Increase in visceral adipose tissue in a woman living with HIV after introduction of integrase strand transfer inhibitor 81
Efavirenz dose reduction in HIV-infected patients: a long-term follow-up 80
The treatment of latent TB infection in HIV-positive people: the Verona experience 80
Raltegravir plus lamivudine as 'maintenance therapy' in suppressed HIV-1-infected patients in real-life settings 80
Dolutegravir monotherapy and body weight gain in antiretroviral naïve patients 76
Efficacy of a reduced dose of darunavir/ritonavir in a cohort of antiretroviral-naive and -experienced HIV-infected patients: a medium-term follow-up 72
Budget impact analysis of efavirenz daily dose reduction at the Verona University Hospital 63
Prior Mycobacterium avium complex infection is linked to immunological nonresponsiveness in HIV-infected patients on highly active antiretroviral therapy 62
Pharmacokinetic exposure and virological efficacy of a reduced atazanavir dose. 54
Short-cycle therapy in {HIV}-infected adults: rilpivirine combination 4 days on/3 days off therapy 44
Real-life comparison of mortality in patients with SARS-CoV-2 infection at risk for clinical progression treated with molnupiravir or nirmatrelvir plus ritonavir during the Omicron era in Italy: a nationwide, cohort study 38
WISE (Web-based Infectious Support for the Elderly) Initiative: Improving Infectious Disease Management in LTCFs-Experience From Northern Italy 15
Totale 5.528
Categoria #
all - tutte 21.265
article - articoli 21.265
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.530


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021338 0 0 21 53 65 47 11 32 21 19 46 23
2021/2022489 44 151 4 66 6 8 5 22 26 15 32 110
2022/20231.035 58 137 83 164 100 256 3 71 122 6 20 15
2023/2024486 26 45 52 39 63 84 6 26 6 28 63 48
2024/20251.148 59 81 37 175 59 27 66 39 184 71 105 245
2025/2026576 256 200 120 0 0 0 0 0 0 0 0 0
Totale 5.528